Viridian Therapeutics Shares Rise on Patient Demand for Thyroid Eye Disease Clinical Trial
Viridian Therapeutics Shares Rise on Patient Demand for Thyroid Eye Disease Clinical Trial
由于患者对甲状腺眼病临床试验的需求增加,Viridian Therapeutics股价上涨。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册